• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉脱维亚人群中成年炎症性肠病患者的硫嘌呤甲基转移酶基因多态性

Thiopurine -methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population.

作者信息

Zalizko Polina, Stefanovics Juris, Sokolovska Jelizaveta, Paramonova Natalia, Klavina Evija, Erts Renars, Rovite Vita, Klovins Janis, Pukitis Aldis

机构信息

Faculty of Medicine, University of Latvia, Raina blv 19, Riga, 1586, Latvia.

Pauls Stradins Clinical University Hospital, Riga, Latvia.

出版信息

Therap Adv Gastroenterol. 2020 Jul 14;13:1756284820937426. doi: 10.1177/1756284820937426. eCollection 2020.

DOI:10.1177/1756284820937426
PMID:32704308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361485/
Abstract

BACKGROUND

Thiopurine methyltransferase (TPMT) plays a significant role in the metabolism of thiopurines, and, for patients with inflammatory bowel disease (IBD), it is useful to perform TPMT genotyping prior to azathioprine (AZA) treatment. In this study, we determined gene polymorphisms in a cohort of IBD patients in Latvia.

METHODS

DNA samples were obtained from 244 IBD patients, and qPCR was performed for detection of rs1800462, rs1800460, and rs1142345 single-nucleotide polymorphisms (SNPs). Three common, non-functional alleles (, and ) were identified (women, 51%; men, 49%). , and allelic variants detected using qPCR were consistent with restriction fragment length polymorphism (RFLP) data.

RESULTS

Among patients, 78% had ulcerative colitis and 22% had Crohn's disease, with 93.9% of the former carrying a wild-type homozygous genotype and 6.1% carrying heterozygous genotypes. The most frequent polymorphisms were (5.3%: two variants: and ), (0.4%), and (0.4%). None of the patients carried a polymorphism and no patients were homozygous for any mutation.

CONCLUSION

This is the first study to identify gene polymorphisms in adult IBD patients in Latvia. The results indicate that the frequency of common TPMT alleles is similar to that of other European populations.

摘要

背景

硫嘌呤甲基转移酶(TPMT)在硫嘌呤的代谢中起重要作用,对于炎症性肠病(IBD)患者,在使用硫唑嘌呤(AZA)治疗前进行TPMT基因分型很有用。在本研究中,我们测定了拉脱维亚一组IBD患者的基因多态性。

方法

从244例IBD患者中获取DNA样本,并进行qPCR以检测rs1800462、rs1800460和rs1142345单核苷酸多态性(SNP)。鉴定出三个常见的无功能等位基因(、和)(女性占51%;男性占49%)。使用qPCR检测到的、和等位基因变体与限制性片段长度多态性(RFLP)数据一致。

结果

在患者中,78%患有溃疡性结肠炎,22%患有克罗恩病,前者93.9%携带野生型纯合基因型,6.1%携带杂合基因型。最常见的多态性是(5.3%:两种变体:和)、(0.4%)和(0.4%)。没有患者携带多态性,也没有患者任何突变的纯合子。

结论

这是第一项在拉脱维亚成年IBD患者中鉴定基因多态性的研究。结果表明,常见TPMT等位基因的频率与其他欧洲人群相似。

相似文献

1
Thiopurine -methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population.拉脱维亚人群中成年炎症性肠病患者的硫嘌呤甲基转移酶基因多态性
Therap Adv Gastroenterol. 2020 Jul 14;13:1756284820937426. doi: 10.1177/1756284820937426. eCollection 2020.
2
Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的硫嘌呤甲基转移酶基因多态性
Digestion. 2009;79(1):58-63. doi: 10.1159/000205268. Epub 2009 Feb 28.
3
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.希腊克里特岛炎症性肠病患者硫嘌呤S-甲基转移酶基因多态性的患病率
Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1284-1289. doi: 10.1097/MEG.0000000000000947.
4
Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.硫嘌呤甲基转移酶基因多态性与炎症性肠病患者中硫唑嘌呤的活性及代谢产物
Endocr Metab Immune Disord Drug Targets. 2019;19(4):541-547. doi: 10.2174/1871530318666181119153522.
5
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.炎症性肠病中的硫嘌呤甲基转移酶变体:巴西患者中的患病率和毒性
World J Gastroenterol. 2014 Mar 28;20(12):3327-34. doi: 10.3748/wjg.v20.i12.3327.
6
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.斯洛伐克炎症性肠病患者硫嘌呤S-甲基转移酶基因突变的患病率。
Bratisl Lek Listy. 2013;114(6):330-2. doi: 10.4149/bll_2013_069.
7
TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.立陶宛炎症性肠病患者的硫嘌呤甲基转移酶(TPMT)和次黄嘌呤-鸟嘌呤磷酸核糖转移酶(ITPA)基因变异:患病率及与硫唑嘌呤相关的副作用
Adv Med Sci. 2016 Mar;61(1):135-40. doi: 10.1016/j.advms.2015.09.008. Epub 2015 Dec 10.
8
Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.斯洛伐克炎症性肠病患者硫嘌呤S-甲基转移酶基因突变的患病率
Bratisl Lek Listy. 2012;113(5):282-4. doi: 10.4149/bll_2012_065.
9
High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.墨西哥系统性红斑狼疮和类风湿关节炎患者中突变型巯基嘌呤 S-甲基转移酶基因型的高频。
Clin Rheumatol. 2018 Apr;37(4):963-970. doi: 10.1007/s10067-017-3955-4. Epub 2017 Dec 20.
10
Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease.希腊炎症性肠病患儿的硫嘌呤甲基转移酶基因型和硫嘌呤S-甲基转移酶活性
Ann Gastroenterol. 2012;25(3):249-253.

引用本文的文献

1
Relationship Between Thiopurine S-Methyltransferase Genotype and Phenotype in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴小儿急性淋巴细胞白血病中硫嘌呤S-甲基转移酶基因型与表型的关系
J Pediatr Pharmacol Ther. 2025 Apr;30(2):212-217. doi: 10.5863/1551-6776-30.2.212. Epub 2025 Apr 14.
2
A bioinformatics approach to the identification of novel deleterious mutations of human TPMT through validated screening and molecular dynamics.通过验证筛选和分子动力学的方法,进行生物信息学分析,以鉴定人类 TPMT 的新型致病变异。
Sci Rep. 2022 Nov 7;12(1):18872. doi: 10.1038/s41598-022-23488-z.

本文引用的文献

1
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients.硫嘌呤 S-甲基转移酶基因型与炎症性肠病患者不良反应的相关性。
Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2
Systematic review with meta-analysis: risk factors for thiopurine-induced leukopenia in IBD.系统评价与荟萃分析:IBD 患者硫嘌呤诱导白细胞减少的危险因素。
Aliment Pharmacol Ther. 2019 Sep;50(5):484-506. doi: 10.1111/apt.15403. Epub 2019 Jul 25.
3
Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease.基因指导下的巯嘌呤剂量调整并未增加炎症性肠病患者的成本。
J Crohns Colitis. 2019 Jul 25;13(7):838-845. doi: 10.1093/ecco-jcc/jjz009.
4
Genome Database of the Latvian Population (LGDB): Design, Goals, and Primary Results.拉脱维亚人群基因组数据库(LGDB):设计、目标和主要结果。
J Epidemiol. 2018 Aug 5;28(8):353-360. doi: 10.2188/jea.JE20170079. Epub 2018 Mar 24.
5
Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.炎症性肠病患者中硫唑嘌呤诱导的骨髓抑制和感染的危险因素,这些患者的硫嘌呤甲基转移酶(TPMT)基因型正常。
Aliment Pharmacol Ther. 2017 Nov;46(10):953-963. doi: 10.1111/apt.14323. Epub 2017 Sep 15.
6
Monitoring thiopurine metabolites in inflammatory bowel disease.监测炎症性肠病中的硫嘌呤代谢物。
Frontline Gastroenterol. 2016 Oct;7(4):301-307. doi: 10.1136/flgastro-2015-100681. Epub 2016 Apr 7.
7
American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.美国胃肠病学会关于炎症性肠病治疗药物监测的学会指南。
Gastroenterology. 2017 Sep;153(3):827-834. doi: 10.1053/j.gastro.2017.07.032. Epub 2017 Aug 3.
8
Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.硫嘌呤S-甲基转移酶作为一种药物遗传学生物标志物:检测的意义及主要方法综述
Cardiovasc Hematol Agents Med Chem. 2017 Nov 8;15(1):23-30. doi: 10.2174/1871525715666170529091921.
9
Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort.与临床表型和外显子数据比较,在儿科 IBD 队列中鉴定硫嘌呤诱导毒性相关基因:TPMT 酶活性。
Sci Rep. 2016 Oct 5;6:34658. doi: 10.1038/srep34658.
10
Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.全基因组方法验证硫嘌呤甲基转移酶活性是一种单基因药物基因组学性状。
Clin Pharmacol Ther. 2017 Mar;101(3):373-381. doi: 10.1002/cpt.463. Epub 2016 Nov 18.